Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2021-04-13 2021-02-22
Drug Identification Number 02407280 02407280
Brand name AURO-ATORVASTATIN AURO-ATORVASTATIN
Common or Proper name Atorvastatin Atorvastatin
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500's 500's
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-02-18 2021-02-18
Estimated end date 2021-04-15 2021-04-15
Actual end date 2021-03-24
Shortage status Resolved Actual shortage
Company comments
Health Canada comments